Company: PFSA
Filing Date: 2025-06-13
Form Type: 10-Q
Source: 0001213900-25-054386
Chunk: 5

Company: Profusa, Inc.
Filing Date: 2025-06-13
Form: 10-Q
Item: Part I, Item 1
Chunk 5
---
 4,519 
  
    Restricted cash – beginning of the period 
     —  
     — 
  
    Cash and Restricted Cash, Beginning of the period 
    $16,204  
    $4,519 
  
    Reconciliation of Cash and Restricted Cash: 

    cash, end of the period 
     —  
     5,314 
  
    Restricted cash – end of the period 
     18,450  
     — 
  
    Cash and Restricted Cash, End of the period 
    $18,450  
    $5,314 

The accompanying notes are an integral part of
the unaudited condensed consolidated financial statements.

4

NORTHVIEW ACQUISITION CORPORATION

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL
STATEMENTS

Note 1 – Description of Organization and Business Operations

NorthView Acquisition Corporation (the “Company”
or “Northview”) is a blank check company incorporated in Delaware on April 19, 2021. The Company was formed for the purpose
of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with
one or more businesses (“Business Combination”). The Company has identified a target company for a business combination and
is consummating the acquisition of Profusa.

The Company has a wholly-owned subsidiary, NV
Profusa Merger Sub Inc. (“Merger Sub”), a Delaware corporation incorporated on October 13, 2022, formed solely in contemplation
of the Merger with Profusa (See Note 6). Merger Sub has not commenced any operations and has only nominal assets and no liabilities or
contingent liabilities, nor any outstanding commitments other than in connection with the Merger.

On December 22, 2021, the Company consummated
its Initial Public Offering (“IPO”) of 18,975,000 units (the “Units”), which included 2,475,000 Units issued
pursuant to the full exercise of the over-allotment option granted to the underwriters. Each Unit consists of one share of common stock
of the Company, par value $0.0001 per share, one right (the “Rights”), and one-half of one redeemable warrant of the Company
(the “Warrants”). Each Right entitles the holder thereof to receive one-tenth (1/10) of one share of common stock. Each W